Human Amyloid Precursor Protein (APP) ELISA Kit

Neuroscience and biomarker research laboratories rely on quantitative immunoassays to track Amyloid Precursor Protein (APP), a type I transmembrane glycoprotein whose proteolytic processing generates the amyloid beta (Aβ) peptides central to Alzheimer's disease pathology. This Assay Genie kit delivers a microplate-based ELISA workflow calibrated for human samples, suited to applications ranging from cerebrospinal fluid biomarker profiling in mild cognitive impairment cohorts to cell culture supernatant analysis of APP cleavage modulators and pharmacological screens for compounds that alter soluble APP fragment release. The 96-assay configuration accommodates longitudinal study designs commonly run in academic core facilities, contract research organizations, and pharmaceutical discovery programs targeting amyloidogenesis and neuroinflammation. Each kit ships with reagents sufficient for the indicated number of determinations; researchers should consult the included product insert for specific handling, reconstitution, and stability guidance prior to first use. For research use only; the kit is not cleared or approved for human diagnostic procedures.